RecallDepth
Class II Ongoing

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.

This recall is currently active, issued July 24, 2024. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
June 28, 2024
Posted
July 24, 2024
Recall Number
D-0601-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
116,144 bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot #s: CNSDH, Exp. 6/30/2024; CNWVM, CNWWH, Exp. 07/31/2024; CNXKW, CNXKY, CNXMB, CNXMH, Exp. 09/30/2024; CPBTP, CPBTV, Exp. 11/30/2024.

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls